Galecto

Galecto Dividend Yield

Dividend Yield of Galecto (GLTO) as of Oct 17, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of Galecto is 2026 - . Dividend Yield of Galecto was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Galecto Stock analysis

What does Galecto do? Galecto Inc., based in Boston, US, is a clinical-stage biotechnology company focused on developing small molecule therapeutics targeting cancer and fibrotic diseases. The company, listed on 29 October 2020, employs 7 full-time staff and is advancing several drug candidates, including GB0139 for idiopathic pulmonary fibrosis, GB1211 for oncology and liver cirrhosis, and GB2064 for myelofibrosis. Galecto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Galecto stock

On Eulerpool you can find the complete historical development of Dividend Yield Galecto since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Galecto historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Galecto

All Key Metrics — Galecto